| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |